Clinical Trials Logo
  1. Home
  2. Healthy
  3. NCT04398719
  4. Details
NCT04398719 Clinical Trial

CBD-Microglia PET Study

Healthy Clinical Trial

Official title:
Effect of Cannabidiol on Microglial Activation and Central Pain-Sensitization

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04398719
Other study ID # 2000026320
Secondary ID
Status Recruiting
Phase Early Phase 1
First received
Last updated
Start date May 7, 2021
Est. completion date March 1, 2025

Study information
Verified date July 2023
Source Yale University
Contact Rajiv Radhakrishnan, MD
Phone 203-974-7489
Email rajiv.radhakrishnan@yale.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to examine the effect of cannabidiol (CBD) pre-treatment on brain microglial activation in healthy human subjects. Secondarily, this study aims to examine the effect of cannabidiol (CBD) pre-treatment on central pain-sensitization in healthy human subjects.

Description:

This study aims to examine the effect of cannabidiol (CBD), pre-treatment, as Epidiolex, on brain microglial activation in healthy human subjects using [11C]PBR28 PET imaging. Secondarily, this study aims to examine the effect of cannabidiol (CBD) pre-treatment on central pain-sensitization in healthy human subjects. Lastly, this research study will also examine the relationship between brain microglial activation and central pain sensitization with CBD pre-treatment.

Recruitment information / eligibility
Status Recruiting
Enrollment 15
Est. completion date March 1, 2025
Est. primary completion date August 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: 1. Men and women aged 18- 55 years 2. No significant medical or neurological illness 3. No implanted metal devices that may pose a risk during MRI scanning 4. Within the annual permissible radiation exposure 5. Able to provide written informed consent. Exclusion Criteria: 1. Current use of any medications 2. Presence of metal in the body 3. Pregnancy or lactation

Study Design

Related Conditions & MeSH terms

Intervention

Radiation:
• [11C]PBR28
The radiotracer, [11C]PBR28, will be administered at the beginning of each PET scan
Drug:
• Low-dose lipopolysaccharide
Subjects will receive intravenous lipopolysaccharide.
• Intradermal Capsaicin
A small dose of capsaicin will be administered by intradermal injection.

Locations
Country Name City State
United States Connecticut Mental Health Center New Haven Connecticut

Sponsors (2)
Lead Sponsor Collaborator
Yale University National Center for Complementary and Integrative Health (NCCIH)

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Microglial activation using [11C]PBR28 PET imaging Difference in microglial activation ([11C]PBR28 VT levels) between the 2 groups (e.g., CBD vs. placebo) 10 Days
Secondary Capsaicin-induced hyperalgesia Difference in capsaicin-induced hyperalgesia between the 2 groups (e.g., CBD vs. placebo) 10 Days
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1